Quality, COAs and testing
Quality is evidence, not a PDF
Quality is a chain of evidence connecting purchase order, lot number, manufacturing record, sample, test method, laboratory result, release decision, storage condition and shipment.
Peptide Biz Guide — Know the industry. Build with clarity.
PEPTIDE
BIZ GUIDE
Insights today. A healthier tomorrow.
Know the industry.
Build with clarity.
Science, regulation, research and the business of peptides—organized into one practical publication.
Prelaunch — the first edition is in editorial preparation. No download is available yet.
PeptideBiz Guide
The Peptide Industry Business Blueprint
Edition in preparation
The industry is moving. Understand what matters.
01
Distinguish the pathways
Understand how approved drugs, compounding, research-use and human investigational research differ, and why the distinction shapes every decision.
02
Ask better supplier questions
Know what a COA does and does not show, and which records should connect a lot to a release decision.
03
Plan accountable operations
Organize owners, evidence and status into a launch-readiness register instead of assumptions.
Chapter explorer
Six themes, eighteen sections
How the market is structured and who does what.
- §1 The market in one page
- §3 The four lanes
- §16 Where the industry is headed
Plain-language science and the evidence behind quality.
- §2 Peptide science without the noise
- §9 Quality, COAs and testing
- §10 Lyophilization, formulation and logistics
The pathways, and the lines between them.
- §4 The 2026 regulatory reset
- §5 503A, 503B and GLP-1
- §6 RUO: what it is and is not
How legitimate human research is organized.
- §7 Human research, IRBs and PepMD
- §18 Sources and further reading
Models, economics, claims and a launch framework.
- §13 Marketing and claims
- §14 Business models and economics
- §15 The 90-day launch framework
- §17 Decision checklists
Manufacturing, suppliers and the delivery stack.
- §8 Manufacturing, API and supplier diligence
- §11 The healthcare delivery stack
- §12 Diagnostics, telehealth and pharmacy
Sample spread · foundation draft excerpt
The 90-day launch framework
Start by classifying
Days 1–15 — classify: customer, product, intended use, entity roles, state footprint, claims and regulatory questions. Create a launch-readiness register with owner, evidence and status.
Who it is for
- Founders & OperatorsStructure decisions, suppliers and claims before you commit capital.
- Clinics & ProvidersUnderstand the delivery stack, pharmacy pathways and marketing lines.
- Researchers & SuppliersFrame research-use, documentation and quality evidence clearly.
- Industry ProfessionalsKeep a single, organized view of a fast-changing field.
Choose how you read
Proposed development pricing — not approved, no live charges.
Single Edition
$29
one-time
- One named monthly edition as PDF
- Corrections to that edition
- No automatic renewal
- Future issues purchased separately
Not yet available — no edition has been published.
PBG Intelligence
$19
per month, renews monthly until canceled
- The current published edition when you join
- Editions released while your membership is paid
- Editorial digest: summary of what changed
- Keep issues you received after canceling
Opens at launch. Join the waitlist below.
| Single edition | PBG Intelligence | |
|---|---|---|
| Billing | One payment | Monthly recurring |
| Access | That edition | Current edition + those released while paid |
| Future editions | Bought separately | Included while paid |
| Cancellation | Nothing to cancel | Anytime; coverage runs to paid-through date |
PBG Brief — free
A short editorial newsletter. Separate from any purchase.
Disclosure
Publisher-affiliated resources
The following organizations are affiliated with the publisher. They are listed for transparency, not as independent endorsements. The guide does not rank or recommend them over alternatives.
Publisher-affiliated
PepMD
Education and research-development support.
Publisher-affiliated
Pure Rx
B2B infrastructure.
Publisher-affiliated
Provider Support
Operations support.
Directory planned, not included in current draft.
Be first to know when the first edition is released.
Educational publication. No medical, legal or regulatory advice, no promised business results and no guaranteed compliance.